Vascular Physician Offer and Report (VAPOR) Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02220686

Acronym

VAPOR

Enrollment

156

Registered

2014-08-20

Start date

2014-08-31

Completion date

2016-03-31

Last updated

2017-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease (PAD)

Keywords

VAPOR, smoking cessation, PAD

Brief summary

The purpose of the study is to see if vascular physicians (your provider) using a combination of proven smoking cessation tools in an organized way can help vascular patients quit smoking better than usual. The doctors where you are being treated have been chosen to either provide: the combination therapy of giving you advice, considering prescribing medications to help you quit smoking, and referring you to a phone quitline, or to continue their usual smoking cessation practices (which may include all, some, or none of the treatments above).

Interventions

BEHAVIORALOffer and Report Protocol

Physician advice to stop smoking, referral to state Quitline, and physician considers prescribing nicotine replacement therapy.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \>18 * Current smoker * Plan to have a Vascular Quality Initiative (VQI) procedure in \> 7 days

Exclusion criteria

* Pregnant Women, Fetuses and Neonates * Children * People with impaired decision-making capacity

Design outcomes

Primary

Measure	Time frame	Description
Efficacy of the Offer and Report protocol for change in smoking status from Baseline Visit to 3 Month Visit	Change in smoking status from Baseline Visit to 3 Month Visit	To assess the efficacy of the Offer and Report protocol (standardized (1) very brief advice, (2) referral to telephone-based smoking cessation counseling, and (3) consideration of prescribing nicotine replacement therapy (NRT)) as compared to usual smoking cessation care by vascular physicians in biochemically-validated 3 month smoking cessation rates. A questionnaire will be completed by the patient at the Baseline visit and another questionnaire will be completed at the 3 month visit to assess the change in smoking status.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026